Table 3. DMPC/2/siRNA treatment of Jurkat T cells, 48 hours from the beginning of transfection.
DMPC/2 | Percentages of Lyp expression | ||
---|---|---|---|
Treatment | 60 minutes | 90 minutes | O/N |
RPMI | 100 | 100 | 100 |
DMPC/2 | 104.4 ± 1.2 | 98.7 ± 2.5 | 97.9 ± 0.5 |
siRNA 20 pmols | 99.9 ± 0,1 | 103.9 ± 3.0 | 103.0 ± 4.6 |
DMPC/2/siRNA 20 pmols | 70.8 ± 1.1 | 90.4 ± 0,1 | 77.5 ± 1.6 |
RPMI | 100 | 100 | 100 |
DMPC/2 | 100.9 ± 4.1 | 93.6 ± 0.3 | 101.9 ± 2.8 |
siRNA 60 pmols | 99.2 ± 0.1 | 97.1 ± 2.6 | 98.6 ± 1.2 |
DMPC/2/siRNA 60 pmols | 65.0 ± 1.5 | 63.1 ± 1.9 | 48.9 ± 0.7 |
RPMI | 100 | 100 | 100 |
DMPC/2 | 100.8 ± 0.2 | 99.1 ± 0,2 | 98.6 ± 6.4 |
siRNA 100 pmols | 101.9 ± 5.8 | 103.0 ± 3.2 | 95.2± 4.1 |
DMPC/2/siRNA 100 pmols | 68.2 ± 4.2 | 67.7 ± 2.1 | 58.1 ± 4.5 |
Representative duplicate experiment (S6 Fig). Results are expressed as mean ± SD.